For: | Leiting JL, Grotz TE. Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis. World J Gastrointest Oncol 2018; 10(10): 282-289 [PMID: 30364780 DOI: 10.4251/wjgo.v10.i10.282] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v10/i10/282.htm |
Number | Citing Articles |
1 |
Guangcai Niu, Xiangdong Ma. Peritoneal cancer index is a prognostic indicator of survival in advanced gastric cancer with peritoneal carcinomatosis. Oncology and Translational Medicine 2020; 6(3): 116 doi: 10.1007/s10330-019-0381-1
|
2 |
Lili Ai, Hao Wang. Effects of propofol and sevoflurane on tumor killing activity of peripheral blood natural killer cells in patients with gastric cancer. Journal of International Medical Research 2020; 48(3): 030006052090486 doi: 10.1177/0300060520904861
|
3 |
Jieun Yun, Sang-Bae Han, Hong Jun Kim, Se-il Go, Won Sup Lee, Woo Kyun Bae, Sang-Hee Cho, Eun-Kee Song, Ok-Jun Lee, Hee Kyung Kim, Yaewon Yang, Jihyun Kwon, Hee Bok Chae, Ki Hyeong Lee, Hye Sook Han. Exosomal miR-181b-5p Downregulation in Ascites Serves as a Potential Diagnostic Biomarker for Gastric Cancer-associated Malignant Ascites. Journal of Gastric Cancer 2019; 19(3): 301 doi: 10.5230/jgc.2019.19.e27
|
4 |
Veena Sangwan, Luai Al-Marzouki, Sanjima Pal, Vivian Stavrakos, Malak Alzahrani, Dorothy Antonatos, Yehonatan Nevo, Sophie Camilleri-Broët, Roni Rayes, France Bourdeau, Betty Giannias, Nicholas Bertos, Swneke Bailey, Simon Rousseau, Jonathan Cools-Lartigue, Jonathan D. Spicer, Lorenzo Ferri. Inhibition of LPS-mediated TLR4 activation abrogates gastric adenocarcinoma-associated peritoneal metastasis. Clinical & Experimental Metastasis 2022; 39(2): 323 doi: 10.1007/s10585-021-10133-8
|
5 |
Antonio Macrì, Federico Morabito. The use of intraperitoneal chemotherapy for gastric malignancies. Expert Review of Anticancer Therapy 2019; 19(10): 879 doi: 10.1080/14737140.2019.1671189
|
6 |
Megan Fallows, Ambareesh Samant, Harry Wilson, Reza Mirnezami. A Systematic Review of Surgical Management Strategies in the Treatment of Peritoneal Carcinomatosis of Neuroendocrine Origin. Current Oncology 2023; 30(7): 6316 doi: 10.3390/curroncol30070466
|
7 |
Si Ying Adelina Ho, Kon Voi Tay. Systematic review of diagnostic tools for peritoneal metastasis in gastric cancer-staging laparoscopy and its alternatives. World Journal of Gastrointestinal Surgery 2023; 15(10): 2280-2293 doi: 10.4240/wjgs.v15.i10.2280
Abstract(299) |
Core Tip(254) |
Full Article(HTML)(1480)
|
Full Article with Cover (PDF)-1061K(66)
|
Full Article (Word)-608K(24)
|
Audio-669K(4)
|
Peer-Review Report-272K(30)
|
Answering Reviewers-55K(32)
|
Supplementary Material-71K(32)
|
Full Article (PDF)-854K(92)
|
Full Article (XML)-169K(36)
|
Times Cited (2)
|
Total Visits (3818)
|
Open
|
8 |
Giorgio Maria Masci, Fabio Ciccarelli, Fabrizio Ivo Mattei, Damiano Grasso, Fabio Accarpio, Carlo Catalano, Andrea Laghi, Paolo Sammartino, Franco Iafrate. Role of CT texture analysis for predicting peritoneal metastases in patients with gastric cancer. La radiologia medica 2022; 127(3): 251 doi: 10.1007/s11547-021-01443-8
|
9 |
K. R. Ishmuratova, K. Sh. Gantsev. New views on pathogenesis and diagnosis of peritoneal carcinomatosis. Creative surgery and oncology 2023; 12(4): 328 doi: 10.24060/2076-3093-2022-12-4-328-336
|
10 |
Xin Hu, Liuxing Wu, Ben Liu, Kexin Chen. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.651056
|
11 |
Marek Mazurek, Małgorzata Szlendak, Alicja Forma, Jacek Baj, Ryszard Maciejewski, Giandomenico Roviello, Luigi Marano, Franco Roviello, Karol Polom, Robert Sitarz. Hyperthermic Intraperitoneal Chemotherapy in the Management of Gastric Cancer: A Narrative Review. International Journal of Environmental Research and Public Health 2022; 19(2): 681 doi: 10.3390/ijerph19020681
|
12 |
Ravi J. Chokshi, Jin K. Kim, Jimmy Patel, Joseph B. Oliver, Omar Mahmoud. Impact of insurance status on overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). Pleura and Peritoneum 2020; 5(3) doi: 10.1515/pp-2020-0105
|